Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2009, Vol. 3 Issue (3) : 363-367     DOI: 10.1007/s11684-009-0064-z
Research articles |
Effect of decoction on CD14 expression in lipopolysaccharide signal transduction pathway of alcohol-induced liver disease in rats
Rui ZHU MD 1, Lin SHEN MD 1, Jianguo LIU MD 1, Weili ZHANG MM 1, Ling YANG MD 2,
1.Department of Traditional Chinese Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; 2.Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China;
Download: PDF(176 KB)  
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  This paper aims to investigate the effects of Zhihuang (枳黄) decoction on CD14 expression in the lipopolysaccharide signal transduction pathway of alcohol-induced liver disease in rats. Seventy-five Wistar rats were randomly divided into three groups. Ethanol (56%, weight/volumn) was intragastrically administrated to 50 rats (14mL/kg body weight per day) for 10 days to establish a model of alcohol-induced liver disease, and 25 of these 50 rats were treated with Zhihuang decoction simultaneously. Liver injury was evaluated by biochemical examination. The plasma content of endotoxin was assayed by biochemistry. The expression of CD14 mRNA and protein in rat liver was measured by reverse transcriptional polymerase chain reaction and immunohistochemistry, respectively. Zhihuang decoction pretreatment significantly protected against acute alcohol-induced liver injury, which was evidenced by the decrease of elevated serum alanine aminotransferase and aspartate aminotransferase. In addition, the level of plasma endotoxin and up-regulation of CD14 was also suppressed by Zhihuang decoction in alcohol-intoxicated rats. Zhihuang decoction can significantly reduce CD14 expression in the lipopolysaccharide signal transduction pathway, which is one of the most important mechanisms of Zhihuang decoction to treat hepatic injury induced by alcohol in rats.
Keywords liver disease      alcohol      Zhihuang decoction      CD14      signal transduction      
Issue Date: 05 September 2009
URL:  
http://academic.hep.com.cn/fmd/EN/10.1007/s11684-009-0064-z     OR     http://academic.hep.com.cn/fmd/EN/Y2009/V3/I3/363
Zhao J, Chen H, Li Y. Protective effect of bicyclol on acute alcohol-inducedliver injury in mice. Eur J Pharmacol, 2008, 586(1): 322―331

doi: 10.1016/j.ejphar.2008.02.059
Moriarty K J, Platt H, Crompton S, Darling W, Blakemore M, Hutchinson S, Proctor D, Brown M, Burtun B, Lipscomb G, Padmakumar K. Collaborative care for alcoholrelated liver disease. Clin Med, 2007, 7(2): 125―128
Zhu R, Yang L, Shen L, Ye J, Liu J G, Hu S J. ANG II-AT1 receptor pathway is involved in the anti-fibrotic effectof β-elemene. J Huazhong Univ SciTechnol [Med Sci], 2009, 29(2): 177―181
Stern M, Carter E A, Walker W A. Food proteins and gut mucosal barrier. IV. Effects ofacute and chronic ethanol administration on handling and uptake ofbovine serum albumin by rat small intestine. Dig Dis Sci, 1986, 31(11): 1242―1248

doi: 10.1007/BF01296527
Parlesak A, Schäfer C, Schütz T, Bode JC, Bode C. Increased intestinal permeability tomacromolecules and endotoxemia in patients with chronic alcohol abusein different stages of alcohol-induced liver disease. J Hepatol, 2000, 32(5): 742―747

doi: 10.1016/S0168-8278(00)80242-1
Fukui H, Brauner B, Bode J C, Bode C. Plasma endotoxinconcentrations in patients with alcoholic and non-alcoholic liverdisease: reevaluation with an improved chromogenic assay. J Hepatol, 1991, 12(2): 162―169

doi: 10.1016/0168-8278(91)90933-3
Bode C, Kugler V, Bode J C. Endotoxemia in patients with alcoholic and non-alcoholiccirrhosis and in subjects with no evidence of chronic liver diseasefollowing acute alcohol excess. J Hepatol, 1987, 4(11): 8―14

doi: 10.1016/S0168-8278(87)80003-X
Nanji A A, Khettry U, Sadrzadeh S M, Yamanaka T. Severityof liver injury in experimental alcoholic liver disease: correlationwith plasma endotoxin, prostaglandin E2, leukotriene B4 and thromboxaneB2. Am J Pathol, 1993, 142(11): 367―373
Mathison J C, Ulevitch R J. The clearance, tissue distribution,and cellular localization of intravenously injected lipopolysaccharidein rabbits. J Immunol, 1979, 123(5): 2133―2143
Zlydaszyk J C, Moon R J. Fate of 51Cr-labeled lipopolysaccharide in tissue culture cellsand livers of normal mice. Infect Immun, 1976, 14(1): 100―105
Bigatello L M, Broitman S A, Fattori L, Di Paoli M, Pontello M, Bevilacqua G, Nespoli A. Endotoxemia,encephalopathy, and mortality in cirrhotic patients. Am J Gastroenterol, 1987, 82(1): 11―15
Lin R S, Lee F Y, Lee S D, Tsai Y T, Lin H C, Lu R H, Hsu W C, Huang C C, Wang S S, Lo K J. Endotoxemia in patients with chronicliver diseases: relationship to severity of liver diseases, presenceof esophageal varices and hyperdynamic circulaton. J Hepatol, 1995, 22(2): 165―172

doi: 10.1016/0168-8278(95)80424-2
Nolan J P. The role of endotoxin in liver injury. Gastroenterology, 1975, 69(6): 1346―1356
Nolan J P, Camara D S. Intestinal endotoxins asco-factorsin liver injury. Immunol Invest, 1989, 18(1―4): 325―337

doi: 10.3109/08820138909112246
Urbaschek R, McCuskey R S, Rudi V, Becker K P, Stickel F, Urbaschek B, Seitz H K. Endotoxin,endotoxin-neutral- lizing-capacity, sCD14, sICAM-1, and cytokinesin patients with various degrees of alcoholic liver disease. Alcohol Clin Exp Res, 2001, 25(2): 261―268

doi: 10.1111/j.1530-0277.2001.tb02207.x
Kitano H, Fukui H, Okamoto Y, Kikuchi E, Matsumoto M, Kikukawa M, Morimura M, Tsujita S, Nagamoto I, Nakatani T, Takaya A, Tsujii T. Role of albumin and high-density lipoprotein as endotoxin-bindingproteins in rats with acute and chronic alcohol loading. Alcohol Clin Exp Res, 1996, 20(1): 73―76

doi: 10.1111/j.1530-0277.1996.tb01735.x
Beutler B. TNF,immunity and inflammatory disease: lessons of the past decade. J Inv Med, 1995, 43(3): 227―235
Jacob C O. Tumor necrosis factor-α in autoimmunity: pretty girl or oldwitch? Immunol Today, 1992, 13(1): 122―125

doi: 10.1016/0167-5699(92)90107-I
Järveläinen H A, Orpana A, Perola M, Savolainen V T, Karhunen P J, Lindros K O. Promoter polymorphism of the CD14 endotoxin receptorgene as a risk factor for alcoholic liver disease. Hepatology, 2001, 33(1): 1148―1153

doi: 10.1053/jhep.2001.24236
Landmann R, Knopf H P, Link S, Sansano S, Schumann R, Zimmerli W. Human monocyte CD14 is upregulated by lipopolysaccharide. Infect Immun, 1996, 64(5): 1762―1769
Paton A. Alcoholin the body. BMJ, 2005, 330(7482): 85―87

doi: 10.1136/bmj.330.7482.85
Yin M, Ikejima K, Wheeler M D, Bradford B U, Seabra V, Forman D T, Sato N, Thurman R G. Estrogen is involved in earlyalcohol-induced liver injury in a rat enteral feeding model. Hepatology, 2000, 31(1): 117―123

doi: 10.1002/hep.510310119
Dai L L, Gong J P, Zuo G Q, Wu C X, Shi Y J, Li X H, Peng Y, Deng W, Li S W, Liu C A. Synthesis of endotoxin receptor CD14protein in Kupffer cells and its role in alcohol-induced liver disease. World J Gastroenterol, 2003, 9(3): 622―626
Yin M, Bradford B U, Wheeler M D, Uesugi T, Froh M, Goyert S M, Thurman R G. Reduced early alcohol-induced liver injury in CD14-deficient mice. J Immunol, 2001, 166(7): 4737―4742
[1] Jiansong Huang,Yulan Zhou,Xiaoyu Su,Yuanjing Lyu,Lanlan Tao,Xiaofeng Shi,Ping Liu,Zhangbiao Long,Zheng Ruan,Bing Xiao,Wenda Xi,Quansheng Zhou,Jianhua Mao,Xiaodong Xi. Roles of integrin β3 cytoplasmic tail in bidirectional signal transduction in a trans-dominant inhibition model[J]. Front. Med., 2016, 10(3): 311-319.
[2] Lixia Gan,Wei Xiang,Bin Xie,Liqing Yu. Molecular mechanisms of fatty liver in obesity[J]. Front. Med., 2015, 9(3): 275-287.
[3] Feng Ye, Adam K. Snider, Mark H. Ginsberg. Talin and kindlin: the one-two punch in integrin activation[J]. Front Med, 2014, 8(1): 6-16.
[4] Limin Mao, Minglei Guo, Daozhong Jin, Bing Xue, John Q. Wang. Group III metabotropic glutamate receptors and drug addiction[J]. Front Med, 2013, 7(4): 445-451.
[5] Hui Dong, Fu’er Lu, Nan Wang, Xin Zou, Jingjing Rao. Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological abnormalities[J]. Front Med, 2011, 5(3): 288-293.
[6] Yuan CHEN, Qi TIAN. The role of protein kinase C epsilon in neural signal transduction and neurogenic diseases[J]. Front Med, 2011, 5(1): 70-76.
[7] Jinzheng LI, Min LI, Bolin NIU, Jianping GONG. Therapeutic potential of stem cell in liver regeneration[J]. Front Med, 2011, 5(1): 26-32.
[8] Jianguo LIU, Zhe ZHANG, Jiechang GAO, Jiwen XIE, Lin YANG, Shenjun HU. Downregulation effects of beta-elemene on the levels of plasma endotoxin, serum TNF-alpha, and hepatic CD14 expression in rats with liver fibrosis[J]. Front Med, 2011, 5(1): 101-105.
[9] Hong-Lian RUAN, Feng-Hua XU, Wen-Sheng LIU, Qi-Sheng FENG, Li-Zhen CHEN, Yi-Xin ZENG, Wei-Hua JIA, . Alcohol and tea consumption in relation to the risk of nasopharyngeal carcinoma in Guangdong, China[J]. Front. Med., 2010, 4(4): 448-456.
[10] Ling XU MM, Feng WANG MM, Xuan-Fu XU MD, Wen-Hui MO BM, Rong WAN MD, Chuan-Yong GUO MD, Xing-Peng WANG MD, . Data mining of microarray for differentially expressed genes in liver metastasis from gastric cancer[J]. Front. Med., 2010, 4(2): 247-253.
[11] Wen YAN MD, Min FENG MD, Pei-Hua WANG MD, Dao-Wen WANG MD, . Effect of bradykinin on bradykinin-B2 receptor in rat aortic vascular smooth muscle cells and the involved signal transduction pathways[J]. Front. Med., 2010, 4(2): 225-228.
[12] Xu WANG MS, Xiao-Wei GONG MD, PhD, Yong JIANG MD, PhD, Yu-Hua LI PhD, . Mitogen-activated protein kinase pathway inhibitors: inhibitors for diseases?[J]. Front. Med., 2010, 4(1): 46-53.
[13] ZHANG Wanming, YUAN Yuesha, BIAN Cangli, TU Xianyu, ZHANG Wen, HUANG Huqiang, WANG Lan. Characterization of Bacillus amyloliquefacien contaminating 75% alcohol disinfectant[J]. Front. Med., 2008, 2(1): 113-116.
[14] ZHOU Guangde, ZHAO Jingmin, DING Xiaohui, PAN Deng, SUN Yanling, YANG Jianfa, ZHAO Yulai. Pathological study of 130 cases of nonalcoholic fatty liver disease based on NASH-CRN system[J]. Front. Med., 2007, 1(4): 413-417.
[15] GONG Xiaowei, WEI Jie, LI Yusheng, CHENG Weiwei, DENG Peng, JIANG Yong. Involvement of p38 mitogen-activated protein kinase in the regulation of platelet-derived growth factor -induced cell migration[J]. Front. Med., 2007, 1(3): 248-252.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed